{
    "medicine_id": "c74cf71e344439df8d57d46b7026d2a1341e98c8",
    "platform_id": "DB05461",
    "metadata": {
        "name": "Adult Formula 50 60 61 v v Solution",
        "composition": "60 61 v v OPC 28326",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in peripheral vascular disease and raynaud s disease",
            "contraindications": {
                "disease": "10 mg and 40 mg was well tolerated during clinical trials with Raynaud s patients",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "At low doses OPC 28326 selectively vasodilates the femoral arterial bed due to its inhibitory action at alpha 2 adrenoceptors while having minimal action on systemic blood pressure heart rate and coronary carotid vertebral renal and mesenteric blood flows",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}